Perindopril erbumine 是长效血管紧张素转换酶(ACE)抑制剂。
Perindopril Erbumine is a potent ACE inhibitor with IC50 of 1.05 nM. Inhibition of this enzyme prevents the formation of angiotensin II from angiotensin I, which in turn prevents vasoconstriction caused by angiotensin II. Angiotensin-converting enzyme (ACE) inhibitor (IC50 = 1.05 nM).
Saline
1 或 2 mg/kg/day口服
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Ceconi C, et al. Eur J Pharmacol, 2007, 577(1-3), 1-6.
[2] Dong et al (2011) Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease. FASEB J. 25 2911.
[3] Takai et al (2004) Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors. Hypertens.Res. 27 213.
分子式 C23H43N3O5 |
分子量 441.6 |
CAS号 107133-36-8 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO >10 mg/mL |
Water ≥88 mg/mL |
Ethanol 50 mM |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02651415 | Metastatic Colorectal Cancer | Drug: Regorafenib|Drug: Perindopril | British Columbia Cancer Agency|Bayer | Phase 2 | 2016-08-01 | 2016-12-15 |
NCT01013155 | Essential Hypertension | Drug: perindopril erbumine | Roxane Laboratories | 2007-05-01 | 2009-11-12 | |
NCT01012687 | Essential Hypertension | Drug: perindopril erbumine | Roxane Laboratories | 2007-04-01 | 2009-11-12 | |
NCT00461903 | Essential Hypertension|Atrial Fibrillation | Drug: Perindopril | Montreal Heart Institute|Servier | Phase 3 | 2007-12-01 | 2015-12-11 |
NCT01682577 | Healthy | Drug: Perindopril 4 mg tablets of PT Dexa Medica|Drug: Perindopril 4 mg tablets of Servier | Dexa Medica Group | 2008-09-01 | 2012-09-06 | |
NCT02777489 | Obesity | Drug: Perindopril | Gene PreDiT|Blueclinical Ltd | Phase 2 | 2016-02-01 | 2017-03-07 |
NCT02213224 | Nonalcoholic Fatty Liver Disease (NAFLD) | Drug: Perindopril|Drug: Telmisartan|Drug: Amlodipine | Nanfang Hospital of Southern Medical University | Phase 4 | 2014-08-01 | 2014-08-08 |
NCT02729441 | Diabetes|Microalbuminuria | Drug: ramipril|Drug: perindopril | Sunnybrook Health Sciences Centre|Servier | Phase 3 | 2010-04-01 | 2016-03-31 |
NCT01948232 | Childhood Cancer Survivors | Drug: Perindopril | The Hospital for Sick Children | Phase 2 | 2013-09-01 | 2015-10-02 |
NCT02299310 | Chronic Kidney Disease | Drug: Valsartan|Drug: Perindopril | Chinese PLA General Hospital | Phase 4 | 2014-11-01 | 2014-11-29 |
NCT01556997 | Essential Hypertension | Drug: XOMA 985|Drug: Amlodipine Besylate|Drug: Perindopril Erbumine | Symplmed Pharmaceuticals LLC | Phase 3 | 2012-02-01 | 2015-09-08 |
NCT01101009 | Hypertension | Drug: Perindopril + amlodipine + if necessary, hydrochlorothiazide|Drug: olmesartan/amlodipine + hydrochlorothiazide, if necessary. | Daiichi Sankyo Europe, GmbH|Daiichi Sankyo Inc. | Phase 4 | 2010-04-01 | 2013-01-14 |
NCT02655029 | Adherence to Medication Regime|Hypertensive Disease | Drug: Perindopril/Indapamide/Amlodipine fixed dose combination | Servier Hellas Pharmaceuticals Ltd. | 2015-11-25 | 2017-03-23 | |
NCT01062451 | Methamphetamine Dependence|Methamphetamine Abuse|Substance Abuse | Drug: Perindopril|Drug: Placebo|Drug: Candesartan | Baylor College of Medicine|National Institute on Drug Abuse (NIDA) | Phase 1 | 2009-05-01 | 2016-09-27 |
NCT01118520 | Abdominal Aortic Aneurysm | Drug: perindopril arginine|Drug: amlodipine 5mgs|Drug: placebo | Imperial College London|National Institute for Health Research, United Kingdom | Phase 2 | 2011-09-01 | 2015-08-04 |
NCT02995954 | Hypertension | Drug: Perindopril/Amlodipine | Guido Iaccarino|Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona | Phase 4 | 2014-01-01 | 2016-12-16 |
NCT01295047 | Marfan Syndrome | Drug: Atenolol|Drug: VERAPAMIL|Drug: Perindopril | Cardiff University | Phase 4 | 2006-07-01 | 2011-02-11 |
NCT00202592 | Hypertension | Drug: Perindopril | Institut de Recherches Internationales Servier|Servier | Phase 2 | 2003-11-01 | 2011-06-15 |
NCT00202553 | Hypertension | Drug: Perindopril | Institut de Recherches Internationales Servier|Servier | Phase 2 | 2003-07-01 | 2011-06-15 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们